Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | -0.76% | +4.56% | +5.50% |
May. 08 | Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target | MT |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- NRBO Stock
- Revisions NeuroBo Pharmaceuticals, Inc.